Characterization of Potential Harm Caused by Electronic Cigarette Flavor Chemicals and their Reaction Products
电子烟用香精化学品及其反应产物潜在危害的表征
基本信息
- 批准号:10438598
- 负责人:
- 金额:$ 68.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAbbreviationsAdultAerosolsAffectAirAnalytical ChemistryBiologicalBiological AssayCaliforniaCell DeathCell physiologyCellsChemicalsDNADataDatabasesDevicesDiseaseDoseElectronic cigaretteEnd Point AssayEnvironmentEpithelial CellsFoundationsFutureGasesGene ExpressionGlycerolHandHealthHeatingHumanIndividualInflammationIsopropanolLibrariesLiquid ChromatographyLiquid substanceLungMalignant NeoplasmsMass FragmentographyMass Spectrum AnalysisMesenchymeMetabolismMethodsModelingMolecularNeoplasm MetastasisNicotineOrganOxidative StressPathway interactionsPersonsPoisonPropylene GlycolsProtocols documentationReactionReportingResearchRiskSamplingScienceSolventsSystemTestingTissuesTobaccoToxic effectToxicologyUnited States National Institutes of HealthUniversitiesWorkairway epitheliumbasecancer cellcell killingchemical reactioncinnamic aldehydeconsumer productcytotoxiccytotoxicitye-cigarette aerosolselectronic cigarette useelectronic liquidepithelial to mesenchymal transitionexperimental studyin vitro Assayinterestliquid chromatography mass spectrometryoxidationresponsetobacco productstoxicanttranscriptome sequencingtumor progressionvaping
项目摘要
Project Summary
Electronic cigarettes (ECs) use heat to aerosolize “e-liquid” mixtures that usually contain high concentrations of
flavor chemicals. This project will purchase 650 commercial e-liquids to: a) identify and quantify the flavor
chemicals used plus their degradation reaction products (RxPs) formed upon vaping; and b) evaluate the
cellular responses to those flavor chemicals often found at >1 mg/ml (viz. “dominant flavor chemicals”, DFCs),
and to the aerosols produced on vaping. Tested will be 550 “popular” refill and cartomizer fluids and 100 fluids
that have been anecdotally reported to cause sickness in users. Work will be conducted at two campuses:
Portland State University for analytical chemistry, and University of California Riverside for human toxicology.
Aim 1 (PSU). DFCs and vaping RxPs will be identified and quantified for the 650 fluids. Aerosols made using
a range of devices at varied power will be collected in isopropanol and analyzed using gas chromatography/
mass spectrometry (GC/MS) and liquid chromatography/MS/MS. Identification will proceed with standards.
RxPs formed from flavor chemicals will be unambiguously distinguished from RxPs from the EC solvents.
Aim 2 (UCR). Vape aerosols made using lab-prepared fluids containing the identified DFCs will be made with
a range of devices, and screened for cytotoxicity in dose-response experiments using in vitro assays in
conjunction with BEAS-2B lung epithelial cells from normal human adults. The aerosols that are most cytotoxic
will be studied in depth using an air-liquid interface exposure system with the 3D EpiAirway platform that
recapitulates human respiratory epithelium. Individual DFCs will be tested using six cancer-related mode-of-
action assays including assays for an epithelial to mesenchymal transition (EMT) that we have observed with
some EC products. Alterations in gene expression will be determined using RNA-seq and affected pathways
identified. Mixtures of DFCs will be tested at the same relative proportions found in consumer products.
Aim 3 (UCR). Since Aim 2 will examine heat generated aerosols, both DFCs and their RxPs products will have
been present. Aim 3 will differentiate the DFCs and RxP toxicities by exposing the 3D EpiAirway platform to
aerosols generated without heat and containing individual DFCs or the identified RxPs from heating. Endpoint
assays will proceed as in Aim 2 to isolate toxicity to individual chemicals.
Summary. Little is known about the health effects of flavor chemicals used in ECs. This project will fill an
important informational gap with comprehensive new data. Specific toxicants will be identified and the effects
of mixing DFCs will be evaluated. Results will be posted on an online database that will be accessible to any
interested persons or organization, and will provide foundational information for future understanding of flavor
chemicals in tobacco products. The data, the first of their kind, will contribute to a foundation of science upon
which the NIH can develop future research directions to protect consumers’ health and protect those exposed
by second- and thirdhand means.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prudence Talbot其他文献
Prudence Talbot的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prudence Talbot', 18)}}的其他基金
Electronic Cigarettes: Emerging Ingredients, Acids, Toxicants, and Indicators of Non-Tobacco Nicotine
电子烟:新兴成分、酸、有毒物质和非烟草尼古丁指标
- 批准号:
10884691 - 财政年份:2023
- 资助金额:
$ 68.19万 - 项目类别:
Characterization of Potential Harm Caused by Electronic Cigarette Flavor Chemicals and their Reaction Products
电子烟用香精化学品及其反应产物潜在危害的表征
- 批准号:
10215535 - 财政年份:2018
- 资助金额:
$ 68.19万 - 项目类别:
Identification and toxicity of chemicals that are linked to EVALI
与 EVALI 相关的化学物质的鉴定和毒性
- 批准号:
10115508 - 财政年份:2018
- 资助金额:
$ 68.19万 - 项目类别:
MOLECULAR ANALYSIS OF THE CORTICAL GRANULE ENVELOPE
皮质颗粒包膜的分子分析
- 批准号:
2026517 - 财政年份:1997
- 资助金额:
$ 68.19万 - 项目类别:
MOLECULAR ANALYSIS OF THE CORTICAL GRANULE ENVELOPE
皮质颗粒包膜的分子分析
- 批准号:
2674083 - 财政年份:1997
- 资助金额:
$ 68.19万 - 项目类别:
相似海外基金
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8077875 - 财政年份:2010
- 资助金额:
$ 68.19万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
7866149 - 财政年份:2010
- 资助金额:
$ 68.19万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8589822 - 财政年份:2010
- 资助金额:
$ 68.19万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8305149 - 财政年份:2010
- 资助金额:
$ 68.19万 - 项目类别: